Early postoperative outcomes following revascularisation for peripheral arterial disease at a tertiary centre under routine clinical conditions (real-world data)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040596

Enrollment

700

Registered

2026-06-17

Start date

2024-01-02

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.20 I70.21 I70.22 I70.23 I70.24 I70.25

Interventions

Group 1: - 30-day or in-hospital morbidity/mortality - Complication rate and spectrum (particularly wound infection

others, e.g. pneumonia, MALE, MACE)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All consecutive patients at a tertiary vascular surgery centre with symptomatic peripheral arterial disease who underwent surgical treatment (TEA, bypass, hybrid)

Exclusion criteria

Exclusion criteria: patients with symptomatic peripheral arterial disease (PAD) who received conservative or endovascular treatment - vascular surgery patients whose primary underlying condition is not PAD - non-vascular surgery patients

Design outcomes

Primary

Measure	Time frame
- 30-day or in-hospital morbidity/mortality - Complication rate and spectrum (particularly wound infection; others, e.g. pneumonia, MALE, MACE) Specific examinations/parameters: 1. Patient ID: General information about the patient, such as gender, weight, height, age, admission type, case number, district, care level, ICD code and details of whether this was a recurrence or primary treatment. 2. Risk and pre-existing conditions: Relevant pre-existing conditions, history of substance use (alcohol and nicotine consumption), and premedication prior to inpatient admission. 3. Diagnostics: Preoperative imaging procedures and ABI value, as well as the pathological findings. 4. Clinical presentation: Classification according to the Fontaine stage and the ‘floor’ principle, as well as the walking distance in cases of claudication, measured on a treadmill. 5. Surgery: Basic data such as date, day of the week, time of day, duration of surgery, incision and suture times, ASA risk classification and OPS numbers were recorded. A distinction was made between purely surgical and hybrid procedures. For surgical procedures, a distinction was made between TEA and bypass procedures. For TEA procedures, it was recorded whether the procedure was performed as closed or semi-open, and with or without a patch/interposition. Additionally, the patch length was documented. For bypass procedures, the bypass material (autologous, allogeneic: PTFE or Dacron, xenogeneic) was specified. For hybrid procedures, it was recorded whether the procedures were performed with or without a stent and which level was affected. 6. Complications: Postoperative length of stay, need for transfusion, as well as general and surgery-specific complications such as wound healing disorders, restenosis and amputations. 7. Outcome: The postoperative ABI value on discharge, follow-up medication with TAHs and/or OAKs, the place of discharge, and any readmission wit	—

Measure

Time frame

- 30-day or in-hospital morbidity/mortality - Complication rate and spectrum (particularly wound infection; others, e.g. pneumonia, MALE, MACE) Specific examinations/parameters: 1. Patient ID: General information about the patient, such as gender, weight, height, age, admission type, case number, district, care level, ICD code and details of whether this was a recurrence or primary treatment. 2. Risk and pre-existing conditions: Relevant pre-existing conditions, history of substance use (alcohol and nicotine consumption), and premedication prior to inpatient admission. 3. Diagnostics: Preoperative imaging procedures and ABI value, as well as the pathological findings. 4. Clinical presentation: Classification according to the Fontaine stage and the ‘floor’ principle, as well as the walking distance in cases of claudication, measured on a treadmill. 5. Surgery: Basic data such as date, day of the week, time of day, duration of surgery, incision and suture times, ASA risk classification and OPS numbers were recorded. A distinction was made between purely surgical and hybrid procedures. For surgical procedures, a distinction was made between TEA and bypass procedures. For TEA procedures, it was recorded whether the procedure was performed as closed or semi-open, and with or without a patch/interposition. Additionally, the patch length was documented. For bypass procedures, the bypass material (autologous, allogeneic: PTFE or Dacron, xenogeneic) was specified. For hybrid procedures, it was recorded whether the procedures were performed with or without a stent and which level was affected. 6. Complications: Postoperative length of stay, need for transfusion, as well as general and surgery-specific complications such as wound healing disorders, restenosis and amputations. 7. Outcome: The postoperative ABI value on discharge, follow-up medication with TAHs and/or OAKs, the place of discharge, and any readmission wit

—

Secondary

Measure	Time frame
- Factors influencing morbidity and mortality - Comparison of TEA, bypass and hybrid procedures - Reintervention characteristics (rate, range) - Other factors: postoperative ABI values Length of stay pre- and post-intervention (General ward, Intensive Care Unit, Intermediate Care Unit)	—

Countries

Germany

Contacts

Public ContactUdo Barth

Universitätsklinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie

udo.barth@med.ovgu.de+49 391 67 15666

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026